Cyclacel Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Cyclacel Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 2.15M shares, a 83% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.15M -10.5M -83% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 1.81M -10.8M -85.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.32M -11.2M -89.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.06M +431K +68.6% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 12.6M +104K +0.83% Sep 30, 2023 10-Q 2023-11-29
Q2 2023 12.6M +1.29M +11.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 12.5M +2.55M +25.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 628K -9.36M -93.7% Dec 31, 2022 10-K 2024-03-21
Q3 2022 12.5M +2.74M +28% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 11.4M +2.12M +22.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 9.99M +759K +8.22% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 9.99M +3.75M +60% Dec 31, 2021 10-K/A 2023-11-29
Q3 2021 9.8M +4.93M +101% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 9.23M +4.37M +89.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 9.23M +8.37M +974% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 6.25M +5.39M +626% Dec 31, 2020 10-K 2022-03-30
Q3 2020 4.86M -12.3M -71.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 4.86M -12.3M -71.7% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 860K -16.3M -95% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 860K -11.6M -93.1% Dec 31, 2019 10-K 2021-03-01
Q3 2019 17.2M +5.2M +43.4% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 17.2M +5.2M +43.4% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 17.2M +5.2M +43.4% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 12.5M +500K +4.17% Dec 31, 2018 10-K 2020-03-05
Q3 2018 12M +300K +2.57% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 12M +7.56M +170% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 12M +7.72M +181% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 12M +7.74M +182% Dec 31, 2017 10-K 2019-03-28
Q3 2017 11.7M +7.45M +175% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 4.44M +1.43M +47.6% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 4.27M -31.3M -88% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 4.26M +1.29M +43.6% Dec 31, 2016 10-K 2018-03-30
Q3 2016 4.25M -30.5M -87.8% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 3.01M -31.4M -91.3% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 35.6M +1.19M +3.47% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 2.97M -20.2M -87.2% Dec 31, 2015 10-K 2017-03-31
Q3 2015 34.7M +12M +53% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 34.4M +11.7M +51.6% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 34.4M +14.6M +73.5% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 23.2M +3.83M +19.8% Dec 31, 2014 10-K 2016-03-29
Q3 2014 22.7M +3.98M +21.3% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 22.7M +4.96M +28% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 19.8M +8.94M +82.1% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 19.4M +10.7M +123% Dec 31, 2013 10-K 2015-03-31
Q3 2013 18.7M +10.3M +122% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 17.7M -41.3M -70% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 10.9M -48.1M -81.6% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 8.69M +941K +12.1% Dec 31, 2012 10-K 2014-03-26
Q3 2012 8.43M -45.8M -84.4% Sep 30, 2012 10-Q 2012-11-16
Q2 2012 59M +12.4M +26.6% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 59M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 7.75M -38.8M -83.4% Dec 31, 2011 10-K 2013-04-01
Q3 2011 54.2M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 46.6M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 46.6M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.